HIV/AIDS: Nigerian researcher calls for clinical trial of his drug
Renowned Nigerian researcher, Prof. Madubuike Ezeibe, has called on the Federal Government to carry out a clinical trial on Aluminum-Magnesium Silicate (AMS), a drug he developed for the treatment of HIV/AIDS.
Ezeibe, a professor of Veterinary Medicine at the Michael Okpara University of Agriculture, Umudike, made the call in Umuahia, Abia state, recently.
Clinical trial is a study that explores whether a medical strategy, treatment, or device is safe and effective for humans.
It shows which medical approaches work best for certain illnesses on groups of people.
According to the professor, he presented a paper on the potential of the drug as both antiviral and raw material, at a world conference on Ethno-pharmacology in Chicago, United States, on May 2, 2016.
He said more than one year after he invented and presented his findings at different international conferences, no authority anywhere in the world had disputed the research findings.
“I, therefore, appeal to the federal government to institute an inter-ministerial committee to carry out clinical trial of the drug in six centres across the country without further delay.
“The committee should comprise Federal Ministries of Health, Education, Environment as well as Science and Technology, with, at least, 1000 sample patients from each state of the federation.
“Some of the findings of the research include that silicates have molecules that are 0.96 nanometer in size while HIV has molecules as big as 110 nanometer,” he said.
